Quick Takeaways
- APYX - Apyx Medical Corp has 14 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 14 Insiders of Apyx Medical Corp
- Symbol
- APYX on Nasdaq
- Location
- Clearwater, FL
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Apyx Medical Corp executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Moshe Citronowicz | Senior Vice President | $1,895,055 | Mixed | 15 Mar 2026 | ||
| Shawn David Roman | Chief Operating Officer | $21,600 | Mixed | 27 Jan 2026 | ||
| Matthew C. Hill | Chief Financial Officer | $9,605 | Filing P/S | 15 May 2025 | ||
| Stavros G. Vizirgianakis | Director | Mixed | 15 May 2025 | |||
| Minnie Baylor-Henry | Director | Mixed | 15 May 2025 | |||
| Tara Semb | Chief Financial Officer | Mixed | 11 Jan 2023 | |||
| Craig A. Swandal | Director | Mixed | 08 Aug 2024 | |||
| Michael Geraghty | Director | Mixed | 08 Aug 2024 | |||
| Lawrence Waldman | Director | Mixed | 15 May 2025 | |||
| Wendy Lauren Levine | Director | Mixed | 15 May 2025 | |||
| Andrew Makrides | Director | Mixed | 10 Aug 2023 | |||
| Charles D. Goodwin II | Chief Executive Officer, Director | Mixed | 15 May 2025 | |||
| Todd Hornsby | Executive Vice President | Mixed | 10 Jan 2024 | |||
| John C. Andres | Director | Mixed | 08 Aug 2024 |
Top shareholders of Apyx Medical Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
10%
|
4,112,705
|
$14,394,468 | +$2,168,145 | 31 Dec 2025 | |
| Archon Capital Management LLC |
13F
|
Company |
7.8%
|
3,213,226
|
$11,246,291 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
13D/G
|
Company |
6%
from 13D/G
|
2,443,035
|
$8,550,623 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.8%
|
1,565,078
|
$5,477,774 | — | 31 Dec 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
2.7%
|
1,104,970
|
$3,867,395 | — | 31 Dec 2025 | |
| Silverberg Bernstein Capital Management LLC |
13F
|
Company |
2.5%
|
1,033,003
|
$3,615,511 | — | 31 Dec 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
1.6%
|
663,541
|
$2,322,390 | — | 31 Dec 2025 | |
| HORIZON KINETICS ASSET MANAGEMENT LLC |
13F
|
Company |
1.5%
|
615,000
|
$2,152,500 | — | 31 Dec 2025 | |
| Moshe Citronowicz |
3/4/5
|
Senior Vice President |
—
mixed-class rows
|
529,504
mixed-class rows
|
$1,895,055 | — | 15 Mar 2026 | |
| BlackRock, Inc. |
13F
|
Company |
1.2%
|
510,980
|
$1,788,432 | — | 31 Dec 2025 | |
| Taylor Frigon Capital Management LLC |
13F
|
Company |
1.1%
|
437,961
|
$1,532,864 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.87%
|
358,829
|
$1,256,736 | — | 31 Dec 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.6%
|
246,435
|
$862,523 | — | 31 Dec 2025 | |
| Huntleigh Advisors, Inc. |
13F
|
Company |
0.57%
|
236,398
|
$827,417 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.54%
|
220,395
|
$771,383 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.49%
|
201,651
|
$705,779 | — | 31 Dec 2025 | |
| Kingsview Wealth Management, LLC |
13F
|
Company |
0.46%
|
188,193
|
$658,676 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.41%
|
168,238
|
$588,834 | — | 31 Dec 2025 | |
| Caption Management, LLC |
13F
|
Company |
0.39%
|
160,407
|
$561,425 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.36%
|
150,081
|
$525,284 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.3%
|
124,506
|
$435,771 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
116,706
|
$408,471 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.26%
|
107,875
|
$377,565 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
105,638
|
$369,734 | — | 31 Dec 2025 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
0.23%
|
94,500
|
$330,750 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.23%
|
93,679
|
$327,877 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
92,701
|
$324,454 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.23%
|
92,693
|
$324,426 | — | 31 Dec 2025 | |
| Z3 Capital Partners, LLC |
13F
|
Company |
0.22%
|
90,059
|
$315,207 | — | 31 Dec 2025 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.21%
|
87,115
|
$304,902 | — | 31 Dec 2025 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.21%
|
85,000
|
$297,500 | — | 31 Dec 2025 | |
| RPg Family Wealth Advisory, LLC |
13F
|
Company |
0.19%
|
76,250
|
$266,875 | — | 31 Dec 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
61,601
|
$215,604 | — | 31 Dec 2025 | |
| SALEM INVESTMENT COUNSELORS INC |
13F
|
Company |
0.11%
|
45,500
|
$159,250 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.09%
|
38,783
|
$131,000 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.08%
|
31,722
|
$111,027 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
25,941
|
$90,794 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
24,069
|
$84,242 | — | 31 Dec 2025 | |
| GREENWOOD CAPITAL ASSOCIATES LLC |
13F
|
Company |
0.06%
|
22,789
|
$79,762 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.05%
|
22,187
|
$77,655 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
21,619
|
$75,667 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.05%
|
20,719
|
$72,517 | — | 31 Dec 2025 | |
| Joel Isaacson & Co., LLC |
13F
|
Company |
0.05%
|
20,500
|
$71,750 | — | 31 Dec 2025 | |
| SCHOLTZ & COMPANY, LLC |
13F
|
Company |
0.05%
|
20,000
|
$70,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
17,687
|
$61,905 | — | 31 Dec 2025 | |
| Lighthouse Investment Partners, LLC |
13F
|
Company |
0.04%
|
17,020
|
$59,570 | — | 31 Dec 2025 | |
| Creative Planning |
13F
|
Company |
0.04%
|
16,900
|
$59,150 | — | 31 Dec 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
11,444
|
$40,054 | — | 31 Dec 2025 | |
| Ledgewood Wealth Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$35,000 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.02%
|
9,934
|
$34,769 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Apyx Medical Corp
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Moshe Citronowicz | APYX | Common Stock | Options Exercise | 8.11% | 37,000 | 493,504 | 15 Mar 2026 | Direct | ||
| Moshe Citronowicz | APYX | Stock option (right to buy) | Options Exercise | -100% | -37,000 | 0 | 15 Mar 2026 | Direct | ||
| Shawn David Roman | APYX | Common Stock | Options Exercise | 12,000 | 12,000 | 27 Jan 2026 | By The Roman Family Revocable Trust | |||
| Shawn David Roman | APYX | Stock option (right to buy) | Options Exercise | -100% | -12,000 | 0 | 27 Jan 2026 | Direct | ||
| Matthew C. Hill | APYX | Stock Option (Option to Buy) | Award | 100,000 | 100,000 | 15 May 2025 | Direct | |||
| Moshe Citronowicz | APYX | Stock Option (Option to Buy) | Award | 36,000 | 36,000 | 15 May 2025 | Direct | |||
| Lawrence J. Waldman | APYX | Stock Option (Option to Buy) | Award | 30,000 | 30,000 | 15 May 2025 | Direct | |||
| Minnie Baylor-Henry | APYX | Stock Option (Option to Buy) | Award | 59,000 | 59,000 | 15 May 2025 | Direct | |||
| Stavros G. Vizirgianakis | APYX | Stock Option (Option to Buy) | Award | 128,000 | 128,000 | 15 May 2025 | Direct | |||
| Charles D. Goodwin II | APYX | Stock Option (Option to Buy) | Award | 193,000 | 193,000 | 15 May 2025 | Direct | |||
| Wendy Lauren Levine | APYX | Stock Option (Option to Buy) | Award | 64,000 | 64,000 | 15 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.